Introduction
============

Cancer survivors may face psychological, physical, social, and economic challenges as a consequence of their illness or treatment.[@b1-clep-4-041] About one-third of cancer patients are diagnosed at an age when they may possibly be caring for children -- minor (0--18 years) and/or young adult (YA) (19--25 years) children[@b2-clep-4-041] -- and this means entire families can be affected by cancer.[@b3-clep-4-041],[@b4-clep-4-041] Children of parents affected by cancer are at risk for emotional and behavioral problems, although the majority cope well and are unlikely to develop such problems.[@b5-clep-4-041] The child's age, their stage of psychological development at the time of diagnosis and disease, and family characteristics modify the psychological burden of a parent's cancer upon the child.[@b6-clep-4-041] Still, up to 25% of children experiencing severe parental illness will experience lowered and/or anxious mood, sleep problems, poor concentration, or difficulties at school.[@b7-clep-4-041] In worst-case scenarios, severe parental illness may cause profound trauma with consequences for later psychosocial functioning.

Consequences of parental cancer have been shown to vary across cancer disease characteristics and by the role, age, and gender of the diagnosed parent.[@b5-clep-4-041],[@b6-clep-4-041],[@b8-clep-4-041]--[@b10-clep-4-041] Reported discrepancies likely reflect the diversity of families that encounter parental cancer: the economic situation, employment status, and marital status of parents, as well as the number of children, place of residence, type of cancer, and prognosis, are all factors likely to mediate the impact of parental cancer upon their offspring.[@b5-clep-4-041],[@b11-clep-4-041],[@b12-clep-4-041] The impact has been found to further differ depending on whether the respondent is the child or the parent in the situation.[@b9-clep-4-041],[@b13-clep-4-041] Finally, observed differences may in part be a consequence of suboptimal reliability and validity of the instruments available to assess children's coping abilities and needs.[@b5-clep-4-041],[@b11-clep-4-041],[@b12-clep-4-041],[@b14-clep-4-041]

In recent years, communication challenges within families and the provision of support programs for involved children have come under increased focus.[@b7-clep-4-041] Still, many families' needs are frequently unmet, and the effort to address the psychosocial aspects of living with parental cancer is recognized as being in its infancy.[@b15-clep-4-041] As a first step, an assessment of the number and characteristics of affected children is important. Weaver et al[@b16-clep-4-041] recently performed an assessment of these factors in the United States, using self-reported survey data with a response rate of around 70%. They used population weights to estimate that there are about 1.6 million cancer survivors residing with a total of about 2.9 million children under the age of 18 years in the United States today.[@b16-clep-4-041] As Weaver et al[@b16-clep-4-041] indicated, these numbers were estimated based upon self-reported data from one region only and the study lacked objective data, which may infer an underestimation of affected persons. Additionally, cancer types with short survival times were underrepresented and the study did not include children over 18 years of age. Estimates of the number of children experiencing parental death from cancer were not available, and calculations of incident cases, relevant for the shaping and development of services, were not performed. Therefore, Weaver et al[@b16-clep-4-041] requested complementary data to confirm their findings, as an account of the children and families affected by parental cancer is important to guide health care services assisting those potentially adversely affected. With this as a background, the present authors have summarized registry information on families and minor and YA children affected by parental cancer and parental death from cancer at a national level, in total as well as on an annual basis, in Norway.

Methods
=======

Cancer patients and their children were identified through the unique eleven-digit personal identification number assigned to all inhabitants of Norway from 1960 onward. The Norwegian National Population Register provided information on date of birth, date of death or migration, dates of changes in marital status, and dates of birth of all children. Information regarding the education level of the parents was obtained from the Norwegian Registry of Education, and the Norwegian Directorate of Taxes provided information on their employment and yearly gross labor incomes. The Cancer Registry of Norway has registered all cancer cases nationwide since 1953. Mandatory reporting from clinicians and pathologists and mandatory use of death certificates ensures complete and excellent-quality data.[@b17-clep-4-041] The Cause of Death Registry provided cause of death data. Descriptive prevalence and incidence statistics were collated, and factors likely to influence parental death were assessed through logistic regression models.

Norway's population was calculated at 4.7 million as of January 1, 2008.[@b18-clep-4-041] Around 32% of the population aged between 17 and 70 years had at least one child under the age of 18 years, and 30% of the population aged between 35 and 70 years had at least one YA child (19--25 years of age). Persons with a history of cancer made up 4.3% and 3.3% of the female and male population, respectively. Of these, 80% were parents, but the majority of their children were older than the cut-off limit of 25 years of age. The present study included all persons 70 years or younger with children under the age of 26 years as of January 1, 2008; children were divided into two subgroups: minors and YAs. Next, two baseline prevalence cohorts were established: one comprised all minors in Norway as of January 1, 2008, and the other included all YAs. Prevalence analyses of sociodemographic characteristics (eg, age, gender, marital status, number of children, education level, and income) of parents and minor and YA children in families with and without parental cancer were undertaken, and parental disease (eg, cancer type, stage of cancer at diagnosis, and duration of illness) and death features were described in detail for the minor and YA children affected by parental cancer ([Tables 1](#t1-clep-4-041){ref-type="table"}--[4](#t4-clep-4-041){ref-type="table"}). Logistic regression models were used to assess factors likely to influence parental death. From the two baseline prevalence cohorts, 2007 data on the incidence of parental cancer diagnoses and the number of minor and YA children affected and not affected, as well as sociodemographic characteristics of parents and minor and YA children, were extracted to obtain estimates of the annual number and percentage of children affected by parental cancer ([Table 5](#t5-clep-4-041){ref-type="table"}). All statistical analyses were performed using SAS software (v 9.2; SAS Institute Inc, Cary, NC). The statistical significance level was set at 5%.

Results
=======

Scope of problem from a population perspective
----------------------------------------------

In 2007 a total of 84,202 women aged between 17 and 70 years had or had previously had cancer. Of these women, 11,374 had 18,642 children aged 18 years or younger. The total for men aged between 17 and 70 years was 67,554, with 9469 of these men having 16,035 children aged 18 years or younger. Similarly, 13,450 women with cancer were parents of 17,623 YA children, whereas 10,568 men with cancer were parents of 13,969 YA children. The total number of minors in Norway with one or two parents with a history of cancer as of January 1, 2008, was thus 34,250, representing 3.1% of minors in Norway as of this date. The corresponding number of YAs was 30,796, representing 8.4% of YAs as of January 1, 2008. The total number of children aged between 0 and 25 years with a parent with a history of cancer was 65,046, corresponding to a population prevalence of 1.4%.

Altogether, 2075 families with 3481 children aged 18 years or younger experienced having a mother (56%) and/or a father (44%) diagnosed with cancer during 2007. This represents 0.3% of all families with minor children at one point in time, and is thus an estimate of the annual number of families affected, assuming stable birth and cancer incidence rates in the relevant age groups. The median age of the minor children was 8 years. A total of 2272 families with 2989 YA children were affected by parental cancer during 2007.

The number of minors who experienced parental death from cancer during 2007 was 665, which corresponds to an annual percentage of 1.9%. The percentage was somewhat higher for fathers than for mothers (2.0% versus 1.8%). The number of YAs who experienced parental death from cancer during 2007 was 805, corresponding to an overall percentage of 2.5% (3.1% for fathers versus 2.1% for mothers).

Impact on minors in Norway with a parent once diagnosed with cancer
-------------------------------------------------------------------

Among the minors with a parent with (or with a history of) cancer in Norway, 54% had (or had previously had) a mother diagnosed with cancer and 47% had (or had previously had) a father diagnosed with cancer. A total of 33% of the minors with fathers with cancer and 23% of the minors with mothers with cancer were not yet born at the time of diagnosis ([Table 1](#t1-clep-4-041){ref-type="table"}). The most common cancers among these parents were lymphomas and skin, brain, testicular, and breast cancers. With the exception of brain tumors, the prognosis is generally good for these cancer forms. Nevertheless, a total of 4.8% of these children experienced parental death from cancer, although this percentage is low compared with the children who had been born before the diagnosis and had lost their parent to cancer.

The remaining 67% and 77% of children were born either at (4%) or before the time of their parent's cancer diagnosis ([Table 1](#t1-clep-4-041){ref-type="table"}). The mean age of the minor children as of January 2008 was 12 years: 11 years if their father had cancer and 13 years if their mother had cancer. Their gender distribution was in line with the overall gender distribution in the population. More than half of the minors in Norway with a parent once diagnosed with cancer also had a parent diagnosed more than 5 years earlier. The most common maternal diagnoses experienced by minors were breast (27%), skin (17%), and cervical (13%) cancer, whereas the most common paternal diagnoses were testicular (25%), skin (15%), and colorectal (11%) cancer. The majority of parents were diagnosed with localized cancers.

One in seven minors with a parent once diagnosed with cancer had experienced parental death from cancer, whereas parental death is uncommon in the general population, being experienced by only about one in 300--400 ([Table 2](#t2-clep-4-041){ref-type="table"}). Parental death was more common when fathers had cancer, and the most lethal diagnoses among fathers were lung, colorectal, and brain tumors ([Tables 2](#t2-clep-4-041){ref-type="table"}--[4](#t4-clep-4-041){ref-type="table"}). Among mothers, the most lethal diagnoses were lung, colorectal, soft tissue, and breast cancer. The highest death risks were observed for parents diagnosed with metastatic cancer. Parents of 427 minors (1.2%) were diagnosed with more than one cancer form, corresponding to around 4.5% of mothers and 3.5% of fathers with cancer, and their risk of death was slightly elevated ([Table 3](#t3-clep-4-041){ref-type="table"}).

[Table 2](#t2-clep-4-041){ref-type="table"} displays parental sociodemographic characteristics for minor and YA children with and without parents with cancer. The age distribution of the fathers with cancer spanned 20--63 years as of January 2008 (median 43.5 years). The age distribution of the mothers spanned 18--62 years (median 41.5 years). On average, parents with cancer were older than parents in the general population. A total of 31% of the parents had an education level no higher than a high school degree, but there was no difference in level of education between parents with and parents without cancer. Around 5.4% of the minors with mothers with cancer lived in households with annual incomes below the poverty margin defined by the Organization for Economic Cooperation and Development.[@b19-clep-4-041] The corresponding percentage for minors with fathers with cancer was 3.9%. The household income distribution for minor children did not change significantly if their mother had cancer or not, whereas minor children of fathers with cancer generally appeared to live in households with income levels below that of the general cancer-free population. The vast majority of minors had parents who were married (only 17% had parents who were separated, divorced, or widowed). Marriage was less common in the general cancer-free population. The minors with parents with a history of cancer had from zero to ten siblings, but most commonly one or two; the average number of siblings was 1.3. The percentage of children with no siblings was lower in the cancer cohort than in the general population.

Impact on YA children in Norway with a parent once diagnosed with cancer
------------------------------------------------------------------------

Cancer is a disease that becomes more common with increasing age, and around 93% of the YA children in this study were born before the time of the diagnosis of parental cancer. Around half had parents diagnosed within the last 5 years ([Table 2](#t2-clep-4-041){ref-type="table"}). Maternal cancer was more prevalent than paternal cancer. The most common diagnoses in mothers were breast, cervical, and skin cancer, whereas diagnoses of colorectal, skin, prostate, and testicular cancer were frequent among fathers ([Table 1](#t1-clep-4-041){ref-type="table"}). Nearly half the parents had localized cancers at the time of diagnosis, but the percentage of patients where the stage was unknown was clearly higher for fathers than mothers. One in four YAs with a parent once diagnosed with cancer had experienced parental death from cancer, whereas parental death is experienced by only one in 80 in the general population ([Table 4](#t4-clep-4-041){ref-type="table"}). Death from cancer was more common in fathers than in mothers, and the most lethal diagnoses were lung and colorectal cancer. As expected, the highest probabilities of death were observed for parents diagnosed with metastatic cancer ([Tables 3](#t3-clep-4-041){ref-type="table"} and [4](#t4-clep-4-041){ref-type="table"}). A total of 796 YAs (2.6%) had parents diagnosed with two or more cancer forms (5.8% of mothers and 4.8% of fathers), and the risk of death for these parents was elevated.

[Table 2](#t2-clep-4-041){ref-type="table"} displays parental sociodemographic characteristics for YAs with and without parents with cancer. The age distribution of the fathers with cancer spanned 21--70 years of age as of January 2008 (median 52.8 years), whereas for mothers the age range spanned 20--70 years (median 49.3 years). Parents with a history of cancer were significantly older, on average, than parents without cancer. Around 43% of the parents had an education level no higher than a high school degree -- this is comparable with general population figures. However, a higher percentage of parents with cancer had education levels corresponding to a bachelor degree or higher. On average, earnings were somewhat lower for parents (regardless of gender) with cancer. The majority of parents with cancer were married (71%), and this figure is comparable with that for parents without cancer. The number of siblings for YA children ranged from zero to twelve, but they most commonly had one or two; the average number of siblings was 1.1. The gender distribution of YAs was fairly equal, and their median age as of January 2008 was 21 years.

Annual impact of parental cancer on minor and YA children
---------------------------------------------------------

Altogether, 2075 families with 3481 children aged 18 years or younger experienced having the mother (56%) and/or the father (44%) diagnosed with cancer during 2007. The most common parental cancer diagnoses were breast, prostate, colorectal, skin, cervical, and testicular cancer, and the majority of cancers were localized ([Table 5](#t5-clep-4-041){ref-type="table"}). A total of 7% of minors experienced maternal cancer diagnosis and maternal death from cancer during the same year, whereas the total for the children of fathers with cancer was 13%. Altogether, 2272 families with 2989 YA children were affected, and the corresponding figures for cancer diagnosis and death from cancer within 1 year were 11% and 17%, respectively.

The size of the families varied, from one parent and one child through to two parents and eleven children, but the two-parent family with two to three children was the most common (60%), comparable with general population figures. Nearly 60% of the parents were married, and 20% were widowed, divorced, and/or separated adults, in line with general population estimates.

Discussion
==========

This nationwide study shows that the annual incidence of parental cancer for minors is 0.3%. At any one point in time, approximately 3% of minors and 8% of YA children have or have had parents once diagnosed with cancer, corresponding to a population prevalence of 1.4%.

Influential sociodemographic factors and existing research
----------------------------------------------------------

The vast majority of minor and YA children have taken part in a parent's cancer journey, and are likely influenced by and involved in their parent's illness and treatment.[@b11-clep-4-041],[@b15-clep-4-041],[@b20-clep-4-041] Around 16% of the minor and YA children had not yet been born at the time of their parent's diagnosis. These children were less likely to be affected by parental cancer, although long-term or late effects may be present in future years; additionally, fear of recurrence may influence family life. Five percent of these children lost their parent to cancer; however, this percentage is low compared with the children who had been born before the diagnosis and had lost their parent to cancer.

The demographic and socioeconomic characteristics of parents with and parents without cancer were fairly similar with respect to marital status and number of children. This was expected, as cancer has only a modest effect on parental marriage or divorce probabilities,[@b21-clep-4-041],[@b22-clep-4-041] and although the likelihood of parenthood is reduced after cancer,[@b23-clep-4-041] the majority of cancer survivors have completed their childbearing by the time of diagnosis. Compared with general population figures, a higher percentage of parents with cancer had earned a bachelor's degree or higher. This may make the children of these parents less at risk than the children of parents with other chronic diseases more closely associated with lower levels of education, as education has been shown to increase health literacy and to facilitate open dialogues.[@b24-clep-4-041]--[@b26-clep-4-041] An understanding of the health and welfare systems may help navigation and thus improve coping and reduce stress, benefitting the children involved. However, incomes were on average lower for parents with cancer. This may reflect the older average age of the parents with cancer and thus the probability of being retired.[@b27-clep-4-041] However, it may also reflect work limitations associated with cancer.[@b27-clep-4-041],[@b28-clep-4-041] Although single parents, most commonly mothers, make up only a small proportion (5%--10%) of parents in Norway, their children may be particularly vulnerable,[@b29-clep-4-041] and research targeting this specific subgroup may be warranted.

Some studies report adverse consequences for children affected by parental cancer, and the children's age and gender has been found to influence the type and degree of problems they experience.[@b6-clep-4-041],[@b9-clep-4-041],[@b13-clep-4-041] However, other studies do not report significant adverse consequences for children.[@b3-clep-4-041],[@b30-clep-4-041] Younger children may not fully comprehend the significance of parental cancer, and thus they may be less affected emotionally than older minors and YAs.[@b9-clep-4-041] Older siblings may support one another, but they may also experience a role shift if they need to assist more with household chores and/or assist with care of the ill parent.[@b8-clep-4-041] How this influences the children and parents involved is debatable, but studies report both positive and negative consequences.[@b5-clep-4-041],[@b8-clep-4-041],[@b11-clep-4-041],[@b12-clep-4-041],[@b31-clep-4-041]

Between one in seven and one in four minor and YA children with parents with a history of cancer experience parental death, whereas parental death is uncommon in the general population. Children experience maternal cancer more often than paternal cancer, but they are more likely to lose a father than a mother to cancer. Studies on how families and minor and YA children cope with terminal care and parental death suggest that parents tend to underestimate the adverse consequences as they are perceived by the children involved, and that open communication and maintaining "normality" are important strategies for optimizing family functioning.[@b32-clep-4-041],[@b33-clep-4-041] Several studies report that the gender of the parent with cancer has implications for the psychosocial and emotional outcomes of the children involved. Most studies suggest that children respond worse to maternal than paternal cancer,[@b13-clep-4-041],[@b34-clep-4-041],[@b35-clep-4-041] perhaps in line with traditional caregiver roles. However, one study reports that the consequences are worse for children of fathers with cancer -- this may reflect the poorer prognosis for fathers.[@b6-clep-4-041] The gender of the children involved is also reported to affect the prevalence and severity of problems reported.[@b5-clep-4-041],[@b11-clep-4-041] As the gender distribution of children is fairly equal and as it is similar for parents with and parents without cancer, the authors do not discuss this further here.

The authors' main findings on minor children of cancer survivors are in accordance with US estimates from Weaver et al,[@b16-clep-4-041] but the current authors present more detailed data on stage at diagnosis and death, and information on YA children is also included. Nonetheless, some important differences are notable: around 54% of the minors who had a parent with a history of cancer had experienced maternal cancer in the current study, whereas this was observed for 79% of the children in Weaver et al's study.[@b16-clep-4-041] These differences may be explained in part by the relatively high lethality of paternal cancer, as only living parents were included in the US study.[@b16-clep-4-041] Selection and/or information bias may also have affected the US survey estimates.[@b36-clep-4-041] Women have been found more likely to respond to surveys and to underreport their cancer diagnosis less frequently than men.[@b37-clep-4-041],[@b38-clep-4-041] Nonetheless, the observed discrepancy underscores the need to confirm survey findings by using additional data sources and the importance of undertaking studies across different cultures.

Generalizability of implications of findings
--------------------------------------------

Data on the entire Norwegian population of minor and YA children as of January 2008 has been utilized, and no earlier investigation has employed such detailed material on such a large scale. The use of national registry data minimizes bias, and the accuracy of population-based estimates resulting from survey data has thus been addressed. Furthermore, the results may be of general interest, as Norwegian cancer incidence and mortality trends and general family behaviors are comparable with those of other developed countries, including the United States.[@b2-clep-4-041],[@b18-clep-4-041],[@b39-clep-4-041] However, Norway is a welfare state, and cancer care is available to all, free of charge. In addition, multiple welfare benefits are endorsed to compensate for declines in earnings. This implies that comparisons of the possible influence of sociodemographic factors are more difficult cross-culturally. However, it seems likely that findings may apply to countries with similar health and welfare options (eg, Canada and other Nordic and Western European countries).

As the data for this study are linked through the children, only the individual and combined characteristics of mothers and fathers can be addressed, not the family as a system per se. Knowledge of actual household members would have improved the estimate of, for instance, the impact of marital status and earnings. It would also have facilitated a better comparison with the existing US population estimates.[@b16-clep-4-041]

Many of the factors useful in assessing needs and planning interventions to assist affected families have been assessed in a complete national population, and the authors have further shown that survey data may underestimate the number of children affected by parental cancer, as parental death, especially of fathers, is a relatively common phenomenon. In January 2010, a Norwegian law was implemented mandating minor children of severely ill parents be included as targets for support within the national health care system.[@b40-clep-4-041] The white papers preceding the law specifically mentioned cancer as one of several illnesses covered, and Norwegian cancer care is now obliged to provide services to assess the presence of minor children, assess their needs, and initiate interventions.[@b41-clep-4-041],[@b42-clep-4-041] Oncologic departments have been required to dedicate one specific health care practitioner to ensuring the presence of minor children is documented in cancer patients' journals and that the needs of involved children are assessed.[@b1-clep-4-041] This health practitioner is further obligated by law to contact social services or other relevant personnel if deemed necessary, irrespective of parental consent.[@b40-clep-4-041]

Around 8% of YAs have or have had a parent diagnosed with cancer, corresponding to a population prevalence of 1.4%. To the best of the authors' knowledge, this study is the first to contribute detailed information of YA children afflicted by parental cancer. Although YAs are independent in the legal sense, many nonetheless depend on parental support -- physically, psychologically, socially, and economically. [@b43-clep-4-041] This dependence may alter when a parent is diagnosed with cancer, and caregiver burdens may in some cases also be reversed.[@b44-clep-4-041]--[@b46-clep-4-041] From a health care perspective, the needs of and follow-up required for YA children in transitional phases will perhaps be different than for minor children, and research to address this difference is warranted.

Finally, information that has not been available previously on cancer prognosis and death from cancer has now been provided. Death is the most serious and dreaded consequence of parental cancer for the minor and YA children involved,[@b5-clep-4-041],[@b11-clep-4-041] and knowledge of the risk of parental death is useful when interacting with children and their parents in cases of parental cancer.

Conclusion
==========

The annual incidence of parental cancer for minor children was 0.3%, whereas the prevalence of having or having had a parent with cancer was 3% among minor children and 8% among YA children, corresponding to a population prevalence of 1.4%. The most common diagnoses experienced by minor and YA children were skin, breast, testicular, and colorectal cancer; this distribution differs somewhat from the cancer distribution in the general population because of the age distribution of parents.[@b2-clep-4-041] One in five minor and YA children experience parental death from cancer -- lung, colorectal, and brain tumors are most lethal. The proportion of children affected by cancer remains similar regardless of whether it is the mother or the father with cancer, but children are much more likely to experience paternal than maternal death. With this as the history, surveys of live respondents likely underestimate the number of children affected by parental cancer, especially fathers.

Adequate assistance for minor and YA children affected by parental cancer requires knowledge of their number and characteristics, as well as the characteristics of their parents. In recent years, communication challenges within families and the provision of support programs for involved children have come under increased focus.[@b7-clep-4-041] Nevertheless, many families' needs are frequently unmet, and the effort to address the psychosocial aspects of living with parental cancer is recognized as being in its infancy.[@b15-clep-4-041] Changes in the Norwegian Health Personnel Law in effect from January 2010 mandate health practitioner assessment of the presence of children when adults are diagnosed with cancer, assessment of the needs of involved children, and instigation of interventions to meet the needs of these children.[@b40-clep-4-041]--[@b42-clep-4-041] This study has provided information at a population level to aid in this work, and the knowledge gained may thus help to understand what is required for the adequate assessment of needs and the proper assistance and follow-up of potentially vulnerable children experiencing parental cancer, particularly those facing parental death.
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###### 

Prevalence data on Norwegian children with parents with cancer: common parental cancer diagnoses, stage of cancer at diagnosis, and the age of the child at diagnosis, as of January 2008

  Variable                                             ICD-10 codes                                                        Cancer in mother   Cancer in father                 
  ---------------------------------------------------- ------------------------------------------------------------------- ------------------ ------------------ ------------- -------------
  Cancer site                                                                                                                                                                  
   Skin                                                C43-C44                                                             3246 (17.4)        2217 (12.6)        2384 (14.9)   1892 (13.5)
   Colorectal                                          C17-C21                                                             1123 (6.0)         1572 (8.9)         1733 (10.8)   2350 (16.8)
   Brain                                               C69-C72, D32-D33                                                    1553 (8.3)         1122 (6.4)         1610 (10.0)   1091 (7.8)
   Endocrine                                           C73-C75                                                             1224 (6.6)         762 (4.3)          405 (2.5)     282 (2.0)
   Leukemia                                            C90-C95                                                             599 (3.2)          371 (2.1)          823 (5.1)     653 (4.7)
   Non-Hodgkin disease                                 C82-C85, C95                                                        561 (3.0)          466 (2.6)          856 (5.3)     877 (6.3)
   Hodgkin disease                                     C81                                                                 467 (2.5)          181 (1.0)          809 (5.0)     324 (2.3)
   Renal/bladder                                       C64-C68                                                             300 (1.6)          314 (1.8)          963 (6.0)     1170 (8.4)
   Lung                                                C34                                                                 284 (1.5)          518 (2.9)          614 (3.8)     1038 (7.4)
   Head and neck                                       C00-C14, C30-C32                                                    196 (1.1)          196 (1.1)          528 (3.3)     575 (4.1)
   Soft tissue                                         C45-C49                                                             162 (0.9)          104 (0.6)          188 (1.2)     131 (0.9)
   Bone                                                C40-C41                                                             130 (0.7)          66 (0.4)           185 (1.2)     89 (0.6)
   Breast                                              C50                                                                 4950 (26.6)        6038 (34.3)        N/A           N/A
   Cervical/uterine                                    C53-C55                                                             2413 (12.9)        2276 (12.9)        N/A           N/A
   Ovarian                                             C56                                                                 1247 (6.7)         1202 (6.8)         N/A           N/A
   Testicular                                          C62-C63                                                             N/A                N/A                4043 (25.2)   1569 (11.2)
   Prostate                                            C61                                                                 N/A                N/A                600 (3.7)     1643 (11.8)
   Other or unknown                                    C76-C80, C88 and others[d](#tfn5-clep-4-041){ref-type="table-fn"}   187 (1.0)          218 (1.2)          294 (1.8)     285 (2.0)
  Stage of cancer at diagnosis                                                                                                                                                 
   Local                                               N/A                                                                 10030 (53.8)       8828 (50.1)        7870 (49.1)   6244 (44.7)
   Regional                                            N/A                                                                 4623 (24.8)        4993 (28.3)        2741 (17.1)   2540 (18.2)
   Metastatic                                          N/A                                                                 1399 (7.5)         1969 (11.2)        1779 (11.1)   2138 (15.3)
   Unknown[e](#tfn6-clep-4-041){ref-type="table-fn"}   N/A                                                                 2590 (13.9)        1833 (10.4)        3645 (22.7)   3047 (21.8)
  Age of child at diagnosis                                                                                                                                                    
   0 y                                                 N/A                                                                 656 (3.5)          201 (1.1)          680 (4.2)     185 (1.3)
   1--4 y                                              N/A                                                                 3647 (19.6)        1252 (7.1)         2959 (18.5)   947 (6.8)
   5--9 y                                              N/A                                                                 4877 (26.2)        2513 (14.3)        3566 (22.2)   1695 (12.1)
   10--14 y                                            N/A                                                                 3377 (18.1)        2985 (16.9)        2274 (14.2)   2052 (14.7)
   ≥15 y                                               N/A                                                                 1714 (9.2)         9737 (55.3)        1321 (8.2)    8048 (57.6)
   Born 1--4 y after diagnosis                         N/A                                                                 1547 (8.3)         387 (2.2)          1808 (11.3)   442 (3.2)
   Born ≥5 y after diagnosis                           N/A                                                                 2824 (15.1)        548 (3.1)          3427 (21.4)   600 (4.3)

**Notes:**

Minor children are those aged between 0 and 18 y;

YA children are those aged between 19 and 25 y;

number of minor and YA children with parents with cancer;

not otherwise specified;

includes parental cancers with unknown stage and leukemias and around 50% of the lymphomas for which no stage was recorded.

**Abbreviations:** ICD-10, International Classification of Diseases, 10th edition; N/A, not applicable; y, years; YA, young adult.

###### 

Sociodemographic parental prevalence characteristics (as of January 2008) for children with and children without parents with cancer

  Variable                                                     Cancer in mother   Cancer in father                 
  ------------------------------------------------------------ ------------------ ------------------ ------------- -------------
  Year of diagnosis                                                                                                
   Before 1980                                                 2.3 (N/A)          2.3 (N/A)          3.4 (N/A)     3.2 (N/A)
   1980--1989                                                  7.1 (N/A)          9.2 (N/A)          9.3 (N/A)     10.5 (N/A)
   1990--1999                                                  27.5 (N/A)         33.0 (N/A)         31.1 (N/A)    28.9 (N/A)
   2000--2007                                                  63.1 (N/A)         55.5 (N/A)         56.2 (N/A)    57.4 (N/A)
  Age at diagnosis                                                                                                 
   \<30 y                                                      24.6 (N/A)         8.2 (N/A)          25.5 (N/A)    7.4 (N/A)
   30--39 y                                                    40.3 (N/A)         23.7 (N/A)         33.3 (N/A)    16.5 (N/A)
   40--49 y                                                    30.9 (N/A)         45.9 (N/A)         27.4 (N/A)    32.9 (N/A)
   50--59 y                                                    4.2 (N/A)          20.9 (N/A)         12.9 (N/A)    34.2 (N/A)
   \>59 y                                                      0.0 (N/A)          1.3 (N/A)          0.9 (N/A)     9.0 (N/A)
  Vital status                                                                                                     
   Alive                                                       86.7 (99.8)        77.9 (99.2)        82.7 (99.2)   68.7 (97.4)
   Dead                                                        13.3 (0.2)         22.1 (0.8)         17.3 (0.8)    31.3 (2.6)
  Age[c](#tfn11-clep-4-041){ref-type="table-fn"}                                                                   
   \<45 y                                                      63.9 (84.1)        19.2 (28.7)        52.0 (71.0)   11.3 (15.3)
   45--49 y                                                    22.9 (11.7)        28.7 (34.2)        22.0 (17.5)   19.9 (28.9)
   50--54 y                                                    11.2 (3.6)         31.0 (25.3)        14.9 (8.1)    27.5 (31.5)
   55--59 y                                                    1.9 (0.5)          15.7 (9.4)         8.0 (2.7)     22.5 (16.7)
   60--64 y                                                    0.2 (0.1)          4.9 (2.2)          3.2 (0.7)     13.5 (6.1)
   \>64 y                                                      N/A                0.5 (0.2)          N/A           5.2 (1.5)
  Education level[c](#tfn11-clep-4-041){ref-type="table-fn"}                                                       
   Up to elementary school                                     20.5 (25.2)        23.6 (29.3)        20.6 (23.8)   22.5 (25.2)
   High school                                                 9.9 (7.1)          19.8 (14.8)        10.3 (7.4)    19.5 (15.6)
   \<3 y of college                                            25.5 (27.0)        19.9 (23.4)        29.4 (32.9)   23.9 (27.4)
   3--4 y of college                                           36.6 (33.7)        31.5 (28.3)        27.7 (25.6)   23.6 (22.4)
   ≥5 y of college                                             7.5 (7.0)          5.1 (4.2)          12.1 (10.3)   10.6 (9.4)
  Annual earnings[c](#tfn11-clep-4-041){ref-type="table-fn"}                                                       
   \$0--\$9999                                                 17.3 (16.8)        24.0 (16.8)        12.6 (8.6)    22.2 (15.4)
   \$10,000--\$19,999                                          6.8 (5.2)          7.4 (3.9)          3.5 (1.9)     5.7 (2.0)
   \$20,000--\$39,999                                          27.3 (24.4)        23.2 (20.5)        9.9 (6.5)     12.3 (5.9)
   \$40,000--\$59,999                                          30.0 (32.7)        27.0 (33.3)        22.7 (20.5)   18.6 (17.4)
   \$60,000--\$79,999                                          12.4 (14.3)        13.4 (18.5)        23.8 (28.7)   19.0 (25.7)
   \$80,000--\$99,999                                          3.2 (3.6)          2.6 (4.2)          11.9 (14.9)   8.9 (14.3)
   ≥\$100,000                                                  3.1 (3.0)          2.5 (2.8)          15.5 (18.9)   13.3 (19.3)
  Marital status[c](#tfn11-clep-4-041){ref-type="table-fn"}                                                        
   Married                                                     64.4 (59.4)        68.7 (66.8)        65.2 (61.1)   72.5 (69.8)
   Not married                                                 35.6 (40.6)        31.3 (33.2)        34.8 (38.9)   27.5 (30.2)
  Children (n)[c](#tfn11-clep-4-041){ref-type="table-fn"}                                                          
   1                                                           13.4 (18.9)        8.7 (7.2)          13.9 (19.3)   7.7 (7.3)
   2                                                           41.9 (40.5)        39.2 (37)          38.3 (38.9)   34.0 (35.2)
   ≥3                                                          44.7 (40.6)        52.0 (55.8)        47.8 (41.8)   58.3 (57.5)

**Notes:**

Minor children are those aged between 0 and 18 y;

YA children are those aged between 19 and 25 y;

as of January 2008 for those alive and at time of death for those deceased.

**Abbreviations:** GP, general population; N/A, not applicable; y, years; YA, young adult.

###### 

Distribution of children with parents with cancer having experienced parental cancer death by January 2008, by parental cancer site and stage of cancer at diagnosis

  Variable                                                       Cancer in mother   Cancer in father          
  -------------------------------------------------------------- ------------------ ------------------ ------ ------
  Cancer site                                                                                                 
   Skin                                                          5.4                9.2                11.7   18.4
   Colorectal                                                    42.5               43.3               45.2   51.1
   Brain                                                         12.6               23.6               23.7   39.3
   Endocrine                                                     2.6                5.0                7.7    13.8
   Leukemia                                                      12.5               33.7               20.9   46.2
   Non-Hodgkin disease                                           10.7               21.9               12.9   30.2
   Hodgkin disease                                               4.5                18.2               5.6    20.4
   Renal/bladder                                                 12.7               19.7               15.9   20.9
   Lung                                                          58.5               73.4               64.2   80.3
   Head and neck                                                 10.2               16.3               22.2   27.0
   Soft tissue                                                   18.5               27.9               14.4   32.1
   Bone                                                          11.5               22.7               18.4   41.6
   Breast                                                        16.0               19.9               N/A    N/A
   Cervical/uterine                                              8.2                15.2               N/A    N/A
   Ovarian                                                       9.6                21.7               N/A    N/A
   Testicular                                                    N/A                N/A                2.0    6.1
   Prostate                                                      N/A                N/A                9.2    10.5
   Other or unknown[d](#tfn17-clep-4-041){ref-type="table-fn"}   38.5               56.0               37.4   50.5
  Stage of cancer at diagnosis                                                                                
   Local                                                         5.6                10.3               8.3    16.6
   Regional                                                      17.7               23.5               21.1   35.3
   Metastatic                                                    61.7               72.0               56.3   74.8
   Unknown[e](#tfn18-clep-4-041){ref-type="table-fn"}            9.5                21.8               14.8   27.6

**Notes:**

Minor children are those aged between 0 and 18 y;

YA children are those aged between 19 and 25 y;

percent-wise distribution of minor and YA children with parents with cancer (17/427 (4%) minor children and 75/796 (9%) YA children lost both parents after cancer and therefore the combined number of mothers and fathers is not shown);

not otherwise specified;

includes parental cancers with unknown stage and leukemias and around 50% of the lymphomas for which no stage was recorded.

**Abbreviations:** N/A, not applicable; y, years; YA, young adult.

###### 

Estimates from logistic regression models of characteristics impacting the likelihood of parental death from cancer among children with parents with cancer

  Variable                                                       Minor children[a](#tfn21-clep-4-041){ref-type="table-fn"}   YA children[b](#tfn22-clep-4-041){ref-type="table-fn"}                       
  -------------------------------------------------------------- ----------------------------------------------------------- -------------------------------------------------------- ------------------- -------------------
  Cancer site                                                                                                                                                                                             
   Other or unknown[c](#tfn23-clep-4-041){ref-type="table-fn"}   1.0 (ref)                                                   1.0 (ref)                                                1.0 (ref)           1.0 (ref)
   Colorectal                                                    3.0 (2.4--3.6)                                              1.6 (1.2--2.0)                                           3.1 (2.6--3.6)      1.1 (0.9--1.4)
   Skin                                                          1.3 (1.0--1.6)                                              0.4 (0.3--0.5)                                           1.3 (1.1--1.6)      0.3 (0.3--0.4)
   Brain                                                         4.5 (3.6--5.6)                                              1.2 (1.0--1.6)                                           5.2 (4.3--6.3)      1.5 (1.2--1.9)
   Lymphoma                                                      0.5 (0.4--0.6)                                              0.3 (0.2--0.4)                                           1.2 (1.0--1.4)      0.4 (0.3--0.5)
   Lung                                                          6.9 (5.4--8.9)                                              3.8 (2.7--5.3)                                           11.5 (9.3--14.2)    4.7 (3.5--6.2)
   Head and neck                                                 1.8 (1.3--2.3)                                              0.6 (0.3--0.9)                                           1.6 (1.2--2.0)      0.7 (0.5--0.9)
   Renal/bladder                                                 1.4 (1.1--1.8)                                              Other                                                    1.3 (1.1--1.6)      Other
   Leukemia                                                      2.3 (1.8--3.0)                                              Other                                                    4.6 (3.7--5.8)      Other
   Testicular                                                    0.1 (0.1--0.2)                                              N/A                                                      0.2 (0.2--0.3)      N/A
   Endocrine                                                     Other                                                       0.1 (0.1--0.2)                                           Other               0.1 (0.1--0.2)
   Breast                                                        N/A                                                         0.7 (0.6--0.9)                                           N/A                 0.9 (0.7--1.1)
   Cervical/uterine                                              N/A                                                         0.4 (0.3--0.5)                                           N/A                 0.5 (0.4--0.6)
   Ovarian                                                       N/A                                                         0.2 (0.2--0.3)                                           N/A                 0.3 (0.2--0.3)
  Stage of cancer at diagnosis                                                                                                                                                                            
   Local                                                         1.0 (ref)                                                   1.0 (ref)                                                1.0 (ref)           1.0 (ref)
   Regional                                                      3.3 (2.8--3.8)                                              4.3 (3.7--4.9)                                           2.7 (2.3--3.1)      3.6 (3.2--4.0)
   Metastatic                                                    21.4 (18.0--25.5)                                           25.5 (21.1--30.7)                                        17.0 (14.6--19.7)   35.5 (29.9--42.1)
   Unknown                                                       2.0 (1.7--2.3)                                              1.8 (1.5--2.2)                                           1.8 (1.6--2.1)      2.8 (2.4--3.3)
  Cancers (n)                                                                                                                                                                                             
   1                                                             1.0 (ref)                                                   1.0 (ref)                                                1.0 (ref)           1.0 (ref)
   ≥2                                                            2.1 (1.6--2.7)                                              1.6 (1.3--2.0)                                           1.9 (1.6--2.3)      1.9 (1.7--2.3)
  Year of diagnosis                                                                                                                                                                                       
   Before 1975                                                   1.0 (ref)                                                   1.0 (ref)                                                1.0 (ref)           1.0 (ref)
   1975--1984                                                    0.9 (0.5--1.6)                                              0.7 (0.3--1.6)                                           2.0 (1.2--3.1)      4.2 (2.1--8.4)
   1985--1994                                                    2.2 (1.3--3.7)                                              3.5 (1.7--7.5)                                           2.8 (1.8--4.4)      7.7 (4.0--15.2)
   1995--2004                                                    2.2 (1.3--3.6)                                              3.4 (1.6--7.2)                                           1.9 (1.2--2.9)      3.6 (1.8--7.1)
   2005 or later                                                 0.9 (0.6--1.6)                                              1.3 (0.6--2.7)                                           0.7 (0.4--1.1)      1.3 (0.7--2.6)
  Age of parent at diagnosis: minor child (YA child)                                                                                                                                                      
   \<20 (\<30) y                                                 1.0 (ref)                                                   1.0 (ref)                                                1.0 (ref)           1.0 (ref)
   20--29 (30--39) y                                             0.7 (0.6--0.9)                                              1.2 (0.9--1.4)                                           1.1 (0.9--1.3)      1.1 (0.9--1.3)
   30--39 (40--49) y                                             1.4 (1.2--1.6)                                              1.8 (1.5--2.1)                                           1.1 (0.9--1.3)      1.0 (0.9--1.1)
   40--49 (50--59) y                                             1.4 (1.2--1.7)                                              1.3 (1.1--1.5)                                           1.1 (0.9--1.3)      0.8 (0.7--0.9)
   ≥50 (≥60) y                                                   1.4 (1.1--1.7)                                              0.8 (0.6--1.1)                                           1.2 (1.0--1.5)      0.9 (0.6--1.4)
  SES of parent: marital status                                                                                                                                                                           
   Not married                                                   1.0 (ref)                                                   1.0 (ref)                                                1.0 (ref)           1.0 (ref)
   Married                                                       1.0 (0.9--1.1)                                              1.0 (0.9--1.1)                                           0.9 (0.81--0.99)    1.0 (0.91--1.10)
  SES of parent: children (n)                                                                                                                                                                             
   1                                                             1.0 (ref)                                                   1.0 (ref)                                                1.0 (ref)           1.0 (ref)
   2                                                             0.6 (0.5--0.8)                                              0.8 (0.7--0.9)                                           0.7 (0.6--0.8)      0.8 (0.7--0.9)
   3                                                             0.6 (0.5--0.7)                                              0.8 (0.7--0.9)                                           0.7 (0.6--0.8)      0.8 (0.7--0.9)
   ≥4                                                            0.6 (0.5--0.8)                                              0.8 (0.6--0.9)                                           0.6 (0.5--0.8)      0.8 (0.7--0.9)
  SES of parent: education level                                                                                                                                                                          
   Elementary school                                             1.0 (ref)                                                   1.0 (ref)                                                1.0 (ref)           1.0 (ref)
   High school                                                   0.9 (0.8--1.1)                                              1.1 (0.9--1.2)                                           0.9 (0.8--0.9)      1.0 (0.9--1.2)
   Some college                                                  0.8 (0.7--0.9)                                              0.7 (0.6--0.8)                                           0.7 (0.6--0.8)      0.6 (0.5--0.7)
   Bachelor's degree                                             0.6 (0.5--0.7)                                              0.6 (0.5--0.7)                                           0.7 (0.6--0.8)      0.7 (0.6--0.8)
   Master's degree or higher                                     0.7 (0.6--0.9)                                              0.5 (0.4--0.7)                                           0.8 (0.7--0.9)      0.7 (0.5--0.8)
   SES of parent: income/\$10,000                                0.9 (0.9--0.9)                                              0.9 (0.9--0.9)                                           0.9 (0.9--0.9)      0.9 (0.9--0.9)
  Birth year: minor child (YA child)                                                                                                                                                                      
   Before 1995 (1983)                                            1.0 (ref)                                                   1.0 (ref)                                                1.0 (ref)           1.0 (ref)
   1995--1999 (1984)                                             0.8 (0.7--0.9)                                              0.8 (0.7--0.9)                                           0.9 (0.8--1.1)      1.1 (0.9--1.3)
   2000--2004 (1985)                                             0.6 (0.5--0.7)                                              0.6 (0.5--0.7)                                           1.0 (0.8--1.1)      0.9 (0.8--1.0)
   2005 or later (1986 or later)                                 0.2 (0.2--0.3)                                              0.3 (0.3--0.4)                                           0.8 (0.7--0.8)      0.9 (0.8--0.9)

**Notes:**

Minor children are those aged between 0 and 18 y;

YA children are those aged between 19 and 25 y;

includes unknown cancer sites and those not listed;

includes missing.

**Abbreviations:** CI, confidence interval; N/A, not applicable; OR, odds ratio; SES, socioeconomic status; y, years; YA, young adult.

###### 

Incident characteristics of children with parents diagnosed with cancer (2007)

  Variable                                                       Cancer in mother   Cancer in father                
  -------------------------------------------------------------- ------------------ ------------------ ------------ ------------
  Child's age at diagnosis                                                                                          
   0--1 y                                                        39 (2.0)           N/A                44 (2.9)     N/A
   1--4 y                                                        328 (16.6)         N/A                268 (17.8)   N/A
   5--9 y                                                        504 (25.5)         N/A                350 (23.2)   N/A
   10--14 y                                                      731 (37.0)         N/A                531 (35.3)   N/A
   15--18 y                                                      376 (19.0)         N/A                313 (20.8)   N/A
   19--20 y                                                      N/A                399 (26.9)         N/A          367 (24.1)
   21--22 y                                                      N/A                428 (28.9)         N/A          426 (28.0)
   23--25 y                                                      N/A                654 (44.2)         N/A          721 (47.4)
  Cancer site                                                                                                       
   Skin                                                          219 (11.1)         128 (8.6)          170 (11.3)   141 (9.3)
   Colorectal                                                    144 (7.3)          170 (11.5)         268 (17.8)   314 (20.7)
   Brain                                                         165 (8.3)          88 (5.9)           126 (8.4)    81 (5.3)
   Endocrine                                                     95 (4.8)           39 (2.6)           18 (1.2)     14 (0.9)
   Leukemia                                                      46 (2.3)           34 (2.3)           91 (6.0)     71 (4.7)
   Non-Hodgkin disease                                           56 (2.8)           57 (3.8)           76 (5.0)     71 (4.7)
   Hodgkin disease                                               43 (2.2)           2 (0.1)            37 (2.5)     15 (1.0)
   Renal/bladder                                                 23 (1.2)           28 (1.9)           138 (9.2)    131 (8.6)
   Lung                                                          49 (2.5)           70 (4.7)           69 (4.6)     122 (8.0)
   Head and neck                                                 18 (0.9)           13 (0.9)           70 (4.6)     51 (3.4)
   Breast                                                        788 (39.8)         608 (41.1)         N/A          N/A
   Cervical/uterine                                              186 (9.4)          136 (9.2)          N/A          N/A
   Ovarian                                                       105 (5.3)          77 (5.2)           N/A          N/A
   Testicular                                                    N/A                N/A                186 (12.4)   41 (2.7)
   Prostate                                                      N/A                N/A                201 (13.3)   435 (28.6)
   Other or unknown[d](#tfn30-clep-4-041){ref-type="table-fn"}   41 (2.1)           31 (2.1)           56 (3.7)     33 (2.2)
  Stage of cancer at diagnosis                                                                                      
   Local                                                         888 (44.9)         562 (37.9)         507 (33.7)   498 (32.8)
   Regional                                                      608 (30.7)         498 (33.6)         256 (17.0)   275 (18.1)
   Metastatic                                                    177 (8.9)          193 (13.0)         205 (13.6)   247 (16.3)
   Unknown[e](#tfn31-clep-4-041){ref-type="table-fn"}            305 (15.4)         228 (15.4)         538 (35.7)   500 (32.9)

**Notes:**

Minor children are those aged between 0 and 18 y;

YA children are those aged between 19 and 25 y;

number of minor and YA children with parents with cancer;

see [Table 1](#t1-clep-4-041){ref-type="table"};

includes parental cancers with unknown stage and leukemias and around 50% of the lymphomas for which no stage was recorded.

**Abbreviations:** N/A, not applicable; y, years; YA, young adult.
